New Enterprise Associates 16, L.P. Marker Therapeutics, Inc. (MRKR) insider trading activity

New Enterprise Associates 16, L.P. is > 10% Shareholder of Marker Therapeutics, Inc.. Currently has a direct ownership of 10.7 Million shares of MRKR, which is worth approximately $58.4 Million. The most recent transaction as insider was on Mar 16, 2021, when has been sold 5,714,285 shares (Common Stock) at a price of $1.75 per share, resulting in proceeds of $9,999,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7M

0% 3M change

0% 12M change

Total Value Held $58.4 Million

New Enterprise Associates 16, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 16 2021	BUY Open market or private purchase	$9,999,999 $1.75 p/Share	5,714,285 Added 34.78%	10,714,285 Common Stock

Also insider at

BHG

Bright Health Group Inc. Healthcare

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

AKUS

Akouos, Inc. Healthcare

> 10% Shareholder

TRVI

Trevi Therapeutics, Inc. Healthcare

> 10% Shareholder

MTCR

Metacrine, Inc. Healthcare

> 10% Shareholder

GNCA

GENOCEA BIOSCIENCES, INC. Healthcare

> 10% Shareholder

NEA